The BalancedInvestor Club

Drug Manufacturers General Industry Analysis

23 companies analyzed • Returns from -207.3% to +70.3%

Company List (23 Results)

View:
Sort:

Industry Performance

(23/23 companies)
2025-09-02 → 2026-08-31
Weighted Avg
+31.3%
Best
+70.3%
Worst
-207.3%
Returns Distribution
Top 5
1. AZN+70.3%2. MRK+54.7%3. LLY+45.4%4. BIIB+43.9%5. AMGN+40.4%
Bottom 5
1. MDCX-207.3%2. SCLX-122.2%3. SCLXW-110.4%4. NSRX-72.1%5. MIRA-59.8%

AZN

+70.3%

AstraZeneca PLC ADR

MRK

+54.7%

Merck & Company Inc

LLY

+45.4%

Eli Lilly and Company

BIIB

+43.9%

Biogen Inc

AMGN

+40.4%

Amgen Inc

JNJ

+40.1%

Johnson & Johnson

OGN

+37.9%

Organon & Co

BMY

+34.3%

Bristol-Myers Squibb Company

GILD

+26.1%

Gilead Sciences Inc

GSK

+25.5%

GlaxoSmithKline PLC ADR

ABBV

+19.1%

AbbVie Inc

NVS

+18.3%

Novartis AG ADR

PFE

+13.0%

Pfizer Inc

AMRN

-8.9%

Amarin Corporation PLC

SNY

-11.1%

Sanofi ADR

NVO

-21.8%

Novo Nordisk A/S

GRFS

-22.6%

Grifols SA ADR

MDCXW

-37.6%

Medicus Pharma Ltd. Warrant

MIRA

-59.8%

MIRA Pharmaceuticals, Inc. Common Stock

NSRX

-72.1%

Nasus Pharma Ltd.

1–20 of 23
Page 1 of 2
Methodology

The Weighted Average return (+31.3%) is calculated using market capitalization as weights. This gives larger companies more influence on the average, providing a more market-representative view.

20 companies with market cap data included: AZN, MRK, LLY, BIIB, AMGN, JNJ, OGN, BMY, GILD, GSK and 10 more...

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer